Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results

OBJECTIVE: Since 2014, cannabidiol (CBD) has been administered to patients with treatment‐resistant epilepsies (TREs) in an ongoing expanded‐access program (EAP). We report interim results on the safety and efficacy of CBD in EAP patients treated through December 2016. METHODS: Twenty‐five US‐based...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Epilepsia
Main Authors: Szaflarski, Jerzy P., Bebin, Elizabeth Martina, Comi, Anne M., Patel, Anup D., Joshi, Charuta, Checketts, Daniel, Beal, Jules C., Laux, Linda C., De Boer, Lisa M., Wong, Matthew H., Lopez, Merrick, Devinsky, Orrin, Lyons, Paul D., Zentil, Pilar Pichon, Wechsler, Robert
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Full‐length Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6175436/
https://ncbi.nlm.nih.gov/pubmed/29998598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.14477
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados